Form 4: Quest Diagnostics Director, Gary M. Pfeiffer, Acquires 1,203 Shares of Common Stock
SEC Form 4 Filing
Director Gary M. Pfeiffer acquired 1,203 shares of Quest Diagnostics common stock on May 15, 2025, through an award of restricted stock units.
Summary
- Gary M. Pfeiffer, a director of Quest Diagnostics Inc., acquired 1,203 shares of common stock on May 15, 2025.
- The acquisition was in the form of restricted stock units.
- Following the transaction, Pfeiffer beneficially owns 30,669 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. The sentiment is neither positive nor negative as it simply reports a transaction.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be informative for investors.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date of transaction: Gary M. Pfeiffer acquired 1,203 shares of Quest Diagnostics common stock. |
| 05/19/2025 | Date of signature on the Form 4 filing. |
Keywords
Quest Diagnostics, Director, Stock Acquisition, Form 4, Beneficial Ownership, DGX, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.